Skip to content
H126H126H126

Drawing based on the label description. No photo yet.

“40 mg, yellow to pale yellow, oval, biconvex, delayed-release tablets imprinted "H126" on one side with black ink and plain on the other side”

H 126 pill

Pill with imprint H 126 is yellow, oval, 12 mm and has been identified as Pantoprazole Sodium DR 40 mg. It is used for heartburn and acid reflux. It is supplied by Direct_rx.

Pantoprazole Sodium DR 40 mg

Imprint
H 126
Strength
40 mg
Used for
Heartburn and acid reflux
Color
Yellow
Shape
Oval
Size
12 mm
Score
No score line
Form
Tablet, delayed release
Manufacturer
Direct_rx
NDC
72189-514, 31722-713, 72189-514-90, 72189-514-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Pantoprazole Sodium DR pills and guides

What is Pantoprazole Sodium DR used for?

Pantoprazole Sodium DR is used for heartburn and acid reflux.

Official uses from the US prescribing label

Pantoprazole Sodium Delayed-Release Tablets are indicated for:

1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)

Pantoprazole Sodium Delayed-Release Tablet is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE). For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established.

1.2 Maintenance of Healing of Erosive Esophagitis

Pantoprazole Sodium Delayed-Release Tablets are indicated for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months.

1.3 Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome

Pantoprazole Sodium Delayed-Release Tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison (ZE) Syndrome.

From the FDA-approved label on DailyMed (published Mar 09, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows H126 and the other side is plain.
  • It is yellow, oval, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Pantoprazole Sodium

Inactive: Sodium Carbonate, Titanium Dioxide, Triethyl Citrate, Calcium Stearate, Lactose Monohydrate, Ferric Oxide Yellow, Hypromelloses, Ammonia, Polysorbate 80, Propylene Glycol, Hydroxypropyl Cellulose, Unspecified, Ferrosoferric Oxide, Methacrylic Acid - Methyl Methacrylate Copolymer (1:1), Sodium Lauryl Sulfate, Shellac, Carnauba Wax

Other pills with imprint H 126

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.